Availability of mobile laboratories can facilitate rapid on-spot detection of pathogens,monitor its presence in certain populations and inform health authorities to take immediate remedial measures.Currently available...Availability of mobile laboratories can facilitate rapid on-spot detection of pathogens,monitor its presence in certain populations and inform health authorities to take immediate remedial measures.Currently available biosafety and biosecurity guidelines and policies may not completely articulate the increased demand to manage mobile units in infectious disease outbreaks in remote parts of the country for rapid diagnosis,and also allows research and epidemiological study take place appropriately.The main objective of this study is to evaluate the current limitations and develop and implement biosafety and biosecurity guidelines as well as the protocols for operations,security,and response plan of mobile biosafety level 2 laboratories and their deployment.Keeping in view the sensitivity of it,a comprehensive plan was developed to address it in view of Global Health Security framework.Biosafety and biosecurity protocols were developed including Risk Assessment Tool(RAT)fitting the needs and strengthen the diagnostic and epidemiological capacity in the field covering remote parts of country to fill the gaps observed during the COVID-19 pandemic.Currently the biosafety and biosecurity best practices guidelines and biosecurity policy and regulations are directed mostly towards static laboratories.A biosafety and biosecurity manual developed to adopt and meet the requirements for MBSL 2.For acute health infectious threats including the COVID-19 outbreak and other epidemics,rapid diagnosis can curb and mitigate the problem before it gets out of its boundaries creating significant health risks for the public and economy.The deployment of mobile laboratories will certainly help in curbing these catastrophes.展开更多
A significant number of biosafety level 2(BSL-2)laboratories have been established in many countries for studies of various types of pathogenic agents and other infectious biological materials.The harmonized managemen...A significant number of biosafety level 2(BSL-2)laboratories have been established in many countries for studies of various types of pathogenic agents and other infectious biological materials.The harmonized management of biological risks in such diverse laboratories thus appears as a real challenge.Zhejiang Province in China has taken the initiative to establish a comprehensively integrated laboratory biosafety management system called SINS(Standardization,Informatization,Normalization and Systematization).The SINS model system has been introduced and adopted in 1,721 BSL-2 laboratories in Zhejiang Province,and thus lead to an increase in the number of biosafety committees from 20%to more than 95%from 2007 to 2018,and the number of biosafety laboratory managers who knows biosafety-related laws and regulations increase from 52.7%to 83.7%from 2009 to 2017.Such achievements indicate that the successful implementation of SINS model has increased the effective control of biological risks in BSL-2 laboratories of the Zhejiang Province.SINS model and its main effects on leading the improvement of laboratory biosafety management was presented in this review.The SINS model helps to strengthen laboratory biosafety and thus effectively reduces occurrence of biosafety-related incidences.This model can potentially be used by other regions or countries where harmonized biosafety management system is still under-developing.展开更多
The novel betacoronavirus(Severe Acute Respiratory Syndrome Coronavirus 2,SARS‐CoV‐2)is a pathogen that causes deadly respiratory disease named coronavirus disease 2019(COVID‐19).The incidence of this disease has i...The novel betacoronavirus(Severe Acute Respiratory Syndrome Coronavirus 2,SARS‐CoV‐2)is a pathogen that causes deadly respiratory disease named coronavirus disease 2019(COVID‐19).The incidence of this disease has increased in the last few months affecting 257,832,881 people in 221 countries and 51,68,069 deaths worldwide according to Worldometer at 04:03 GMT on November 22,2021.Thus,the emergence of this disease creates a challenge for health care providers in handling this pathogen and reducing its risk of transmission.In developing countries,this virus is treated in biosafety level 2 laboratories,where a high concentration of pathogen can easily affect the laboratory staff and cause the spread of this disease.Based on the epidemiology and characteristics of the SARS‐CoV‐2 virus already discussed in recent studies,we will provide biosafety guidelines and suggestions for safe handling and transportation of the SARS‐CoV‐2 virus in dealing with the current pandemic situation with a focus on increased infectivity of emerging new variants.展开更多
A biosafety laboratory is a prerequisite for studying emerging infectious diseases.Safe and effective operation in laboratories and the handling of pathogens determine the safety of the personnel,pathogens,and the env...A biosafety laboratory is a prerequisite for studying emerging infectious diseases.Safe and effective operation in laboratories and the handling of pathogens determine the safety of the personnel,pathogens,and the environment in the laboratory,which are among the key factors for successful experimentation.In this article,we aimed to provide ideas for the emergency management of biosafety laboratories,including a discussion on the urgency of the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)related experimental activities,tracking clinical information,taking emergency measures,revision of the risk assessment process,and standardization of personal protective equipment and personnel behavior standards.展开更多
文摘Availability of mobile laboratories can facilitate rapid on-spot detection of pathogens,monitor its presence in certain populations and inform health authorities to take immediate remedial measures.Currently available biosafety and biosecurity guidelines and policies may not completely articulate the increased demand to manage mobile units in infectious disease outbreaks in remote parts of the country for rapid diagnosis,and also allows research and epidemiological study take place appropriately.The main objective of this study is to evaluate the current limitations and develop and implement biosafety and biosecurity guidelines as well as the protocols for operations,security,and response plan of mobile biosafety level 2 laboratories and their deployment.Keeping in view the sensitivity of it,a comprehensive plan was developed to address it in view of Global Health Security framework.Biosafety and biosecurity protocols were developed including Risk Assessment Tool(RAT)fitting the needs and strengthen the diagnostic and epidemiological capacity in the field covering remote parts of country to fill the gaps observed during the COVID-19 pandemic.Currently the biosafety and biosecurity best practices guidelines and biosecurity policy and regulations are directed mostly towards static laboratories.A biosafety and biosecurity manual developed to adopt and meet the requirements for MBSL 2.For acute health infectious threats including the COVID-19 outbreak and other epidemics,rapid diagnosis can curb and mitigate the problem before it gets out of its boundaries creating significant health risks for the public and economy.The deployment of mobile laboratories will certainly help in curbing these catastrophes.
基金This study was part of the Project of Health and Medical Technology of Zhejiang Province funded by the Health Commission of Zhejiang Province(2020KY536).
文摘A significant number of biosafety level 2(BSL-2)laboratories have been established in many countries for studies of various types of pathogenic agents and other infectious biological materials.The harmonized management of biological risks in such diverse laboratories thus appears as a real challenge.Zhejiang Province in China has taken the initiative to establish a comprehensively integrated laboratory biosafety management system called SINS(Standardization,Informatization,Normalization and Systematization).The SINS model system has been introduced and adopted in 1,721 BSL-2 laboratories in Zhejiang Province,and thus lead to an increase in the number of biosafety committees from 20%to more than 95%from 2007 to 2018,and the number of biosafety laboratory managers who knows biosafety-related laws and regulations increase from 52.7%to 83.7%from 2009 to 2017.Such achievements indicate that the successful implementation of SINS model has increased the effective control of biological risks in BSL-2 laboratories of the Zhejiang Province.SINS model and its main effects on leading the improvement of laboratory biosafety management was presented in this review.The SINS model helps to strengthen laboratory biosafety and thus effectively reduces occurrence of biosafety-related incidences.This model can potentially be used by other regions or countries where harmonized biosafety management system is still under-developing.
文摘The novel betacoronavirus(Severe Acute Respiratory Syndrome Coronavirus 2,SARS‐CoV‐2)is a pathogen that causes deadly respiratory disease named coronavirus disease 2019(COVID‐19).The incidence of this disease has increased in the last few months affecting 257,832,881 people in 221 countries and 51,68,069 deaths worldwide according to Worldometer at 04:03 GMT on November 22,2021.Thus,the emergence of this disease creates a challenge for health care providers in handling this pathogen and reducing its risk of transmission.In developing countries,this virus is treated in biosafety level 2 laboratories,where a high concentration of pathogen can easily affect the laboratory staff and cause the spread of this disease.Based on the epidemiology and characteristics of the SARS‐CoV‐2 virus already discussed in recent studies,we will provide biosafety guidelines and suggestions for safe handling and transportation of the SARS‐CoV‐2 virus in dealing with the current pandemic situation with a focus on increased infectivity of emerging new variants.
基金This work was supported by the 13th Five-Year National Science and Technology Major Project of China(grant number 2018ZX10734401-011).
文摘A biosafety laboratory is a prerequisite for studying emerging infectious diseases.Safe and effective operation in laboratories and the handling of pathogens determine the safety of the personnel,pathogens,and the environment in the laboratory,which are among the key factors for successful experimentation.In this article,we aimed to provide ideas for the emergency management of biosafety laboratories,including a discussion on the urgency of the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)related experimental activities,tracking clinical information,taking emergency measures,revision of the risk assessment process,and standardization of personal protective equipment and personnel behavior standards.
